Antimicrobial resistance in Staphylococcus aureus

被引：31

作者：

Smith, TL ^{[1
]}

Jarvis, WR ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Hosp Infect Program, Natl Ctr Infect Dis, Atlanta, GA 30333 USA

来源：

MICROBES AND INFECTION | 1999年 / 1卷 / 10期

关键词：

Staphylococcus aureus; antimicrobials; resistance;

D O I：

10.1016/S1286-4579(99)80082-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Recognized since 1883 as a common cause of infection, Staphylococcus aureus' preantimicrobial-era bacteremia mortality rate was 82%. The mortality of that era threatens to return as evidence of growing vancomycin resistance undermines the utility of vancomycin therapy. Successful treatment of S. aureus infections requires knowledge of its antimicrobial resistance capacity. (C) Elsevier, Paris.

引用

页码：795 / 805

页数：11

共 101 条

[81] TEICOPLANIN SELECTS FOR STAPHYLOCOCCUS-AUREUS THAT IS RESISTANT TO VANCOMYCIN [J].

SHLAES, DM ;

SHLAES, JH .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :1071-1073

[82] Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin [J].

Sieradzki, K ;

Roberts, RB ;

Serur, D ;

Hargrave, J ;

Tomasz, A .

LANCET, 1998, 351 (9106) :880-881

[83] Low-level teicoplanin resistance and heteroresistance to vancomycin [J].

Sieradzki, K ;

Villari, P ;

Tomasz, A .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) :245-245

[84] Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus [J].

Sieradzki, K ;

Tomasz, A .

JOURNAL OF BACTERIOLOGY, 1997, 179 (08) :2557-2566

[85]

Sieradzki K, 1996, FEMS MICROBIOL LETT, V142, P161

[86] Significance of bacteremia caused by Staphylococcus aureus - A study of one hundred and twenty-two cases and a review of the literature concerned wiih experimental infection in animals [J].

Skinner, D ;

Keefer, CS .

ARCHIVES OF INTERNAL MEDICINE, 1941, 68 (05) :851-875

[87] RESISTANCE TO ANTIBIOTICS MEDIATED BY TARGET ALTERATIONS [J].

SPRATT, BG .

SCIENCE, 1994, 264 (5157) :388-393

[88] GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin [J].

Stieger, M ;

Angehrn, P ;

Wohlgensinger, B ;

Gmunder, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :1060-1062

[89] Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides [J].

Tenover, FC ;

Lancaster, MV ;

Hill, BC ;

Steward, CD ;

Stocker, SA ;

Hancock, GA ;

O'Hara, CM ;

Clark, NC ;

Hiramatsu, K .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (04) :1020-1027

[90] DIHYDROFOLATE REDUCTASES IN SOME FOLATE-REQUIRING BACTERIA WITH LOW TRIMETHOPRIM SUSCEPTIBILITY [J].

THEN, RL ;

RIGGENBACH, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (01) :112-117

← 2 3 4 5 6 7 8 9 10 11 →